| Drug Name |
Vilazodone hydrochloride |
| Drug ID |
BADD_D02356 |
| Description |
Vilazodone is a novel compound with combined high affinity and selectivity for the 5-hydroxytryptamine (5-HT) transporter and 5-HT(1A) receptors[Label,A177622]. Vilazodone may also be associated with less sexual dysfunction and weight gain[A6947]. Vilazodone was given FDA approval on January 21, 2011[L6046,A177622]. |
| Indications and Usage |
Vilazodone is approved for treatment of major depressive disorder.[Label,A38477,A177622] |
| Marketing Status |
approved |
| ATC Code |
N06AX24 |
| DrugBank ID |
DB06684
|
| KEGG ID |
D09699
|
| MeSH ID |
D000069503
|
| PubChem ID |
6918313
|
| TTD Drug ID |
D0X6BV
|
| NDC Product Code |
0456-1141; 65129-2248; 16729-353; 55111-955; 65015-848; 16729-354; 55154-4624; 60505-4773; 0480-2044; 72603-127; 76282-545; 50370-0035; 65372-1203; 60505-4772; 0480-2043; 0480-2045; 60505-4774; 69097-981; 76282-544; 66039-903; 16729-352; 46708-233; 62332-232; 0456-1110; 46708-232; 69097-982; 72603-125; 46708-234; 0456-1100; 0456-1101; 76282-546; 51407-691; 55154-4627; 0456-1140; 72603-126; 0456-1111; 51407-692; 51407-693; 62332-233; 62332-234; 0456-1120; 69097-979; 0456-1121 |
| UNII |
U8HTX2GK8J
|
| Synonyms |
Vilazodone Hydrochloride | Hydrochloride, Vilazodone | 2-benzofurancarboxamide, 5-(4-(4-(5-cyano-1H-indol-3-yl)butyl)-1-piperazinyl)-, hydrochloride (1:1) | Vilazodone HCl | HCl, Vilazodone | Viibryd | EMD 68843 | 68843, EMD | EMB-68843 | EMB 68843 | EMB68843 | Vilazodone | 5-(4-(4-(5-cyano-3-indolyl)butyl)-1-piperazinyl)benzofuran-2-carboxamide |
